Similar Articles
Serum Catestatin Levels and Its Relationship with Disease Activity in Patients with Ankylosing Spondylitis
Tugba Alisik, Yagmur Cagla Reis Altan, Murat Alisik, Baris Nacir
DOI: 10.5152/ArchRheumatol.2025.11014
Issue: Volume 40 - Issue 2 - June 2025
2209
813
A Pilot Study on the Anti-Inflammatory Effects of Tacrolimus in Ankylosing Spondylitis: Evidence from Human Samples and a Murine Model
Sooin Park, Moon-Ju Kim, Yu Jeong Lee, Sung Min Yu, Hae-in Lee, So-Hee Jin, A-ra Choi, Seung Cheol Shim, Eun Jeong Won, Tae-Jong Kim
DOI: 10.5152/ArchRheumatol.2025.11154
Issue: Volume 40 - Issue 2 - June 2025
1934
753
Gut Microbiota Mediator Level and Its Relation to Disease Activity in Ankylosing Spondylitis
Hasan Nasrallah, Özlem Altındağ, Mazlum Serdar Akaltun, Mehmet Akif Bozdayı, Mustafa Örkmez, Elif Balbal, Ali Gür
DOI: 10.5152/ArchRheumatol.2025.11048
Issue: Volume 40 - Issue 3 - September 2025
1463
353
Temporal Trend and Health Inequality in the Burden of Autoimmune Diseases Among Older Adolescents and Young Adults Aged 15-29 Years
Sheng Li, Yan-yu Zhu, Harry Asena Musonye, Qian-qian Shi, Hai-fen Wei, Shu-shan Zhao, Hai-feng Pan, Peng Wang
DOI: 10.5152/ArchRheumatol.2025.11174
Issue: Volume 40 - Issue 3 - September 2025
1944
354
Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
Siyao Wu, Wanling Xu, Zhen Bei, Junpei Wu, Mingchun Zhang
DOI: 10.5152/ArchRheumatol.2025.25013
Issue: Volume 40 - Issue 3 - September 2025
1952
507